🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with japan glp-1 access? Page 6

Has anyone dealt with japan glp-1 access?

Dr.PeteFamMed Fri, Oct 18, 2024 at 5:49 PM 35 replies 1,913 viewsPage 6 of 7
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Oct 22, 2024 at 2:45 PM#26

Adding the clinical framing, because it changes how the question reads. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

19 19DebRD_ATL, KristenIndy, MarkLI_maint and 16 others
Reply Quote Save Share Report
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Oct 22, 2024 at 11:38 PM#27
VendorMark said:
Start from the measurement rather than the conclusion.

Adding a me-too, because a thread of one person's experience is not much use.

18 18Dr.EndoEP, GraceAZ_72, carl_compliance and 15 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Oct 23, 2024 at 8:31 AM#28
VendorMark said:
Start from the measurement rather than the conclusion.

There is a second half to this that has not been said yet. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

17 17LondonLisa, mike_nyc, VendorMark and 14 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Oct 23, 2024 at 5:24 PM#29

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

That is the short version; the long version is somebody else's post.

16 16sophie_paris, mel_PDX, Dr.AddMedPHL and 13 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Oct 24, 2024 at 2:18 AM#30

OP back with an update, since a thread like this is useless without one.

For the archive: it took about six weeks rather than the two I expected, and the difference between those two numbers was the whole of my problem.

44 19FranDenver, Dr.BariatricHTX, LindaRN_retired and 41 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register